Many antibiotics in clinical use were developed from fungal and actinomycetes metabolites. During the last decades several pathogenic microorganisms developed resistance to the available antibiotics. Infections by multidrug resistant isolates of Candida spp., Staphylococcus epidermidis, S. aureus, Streptococcus spp., Enterococcus sp. and Escherichia coli, among others, became more and more frequent stimulating the search for new antibiotics with novel mechanisms of action (Kotra & Mobashery 1998 , Morschhäuser et al. 2000 , Sandven 2000 , Thomson & Moland 2000) .
The first investigations on the potential of basidiomycetes as sources of antibiotics were performed by Anchel, Hervey, Wilkins in 1941 (Sandven 2000 , when they examined extracts of fruiting bodies and mycelia culture from over 2000 species. They succeed in the isolation and identification of pleuromutilin (Kavanagh et al. 1950) , a diterpene that is especially useful for the treatment of mycoplasm infections in animals (Brizuela et al. 1998 ) and served for the development of the first commercial antibiotic of basidiomycete origin.
Moreover, interest in the metabolites produced by basidiomycetes declined as streptomycetes were considered to be a more prolific and easier to manipulate source of antibiotics (Anke 1989) . However, over 6000 metabolites were already identified from these imperfect fungi, making it more and more difficult to isolate novel bioactive metabolites from them. With the development of new fermentation and purification technologies, basidiomycetes are again receiving attention as potential sources of new classes of antibiotics (Anke 1989 , Maziero et al. 1999 , Suay et al. 2000 .
In fact, several compounds that inhibit the growth of a large spectrum of saprophytic and phytopathogenic fungi were isolated from basidiomycetes (Anke 1989 (Anke , 1995 (Anke , 1997 . Furthermore, these organisms are able to inhibit the development of bacteria, actinomycetes and other fungi from their microhabitat, indicating that the antimicrobial substances produced by them have important ecological implications (Sidorova & Velikanov 2000) . Despite their potential and enormous diversity in tropical ecosystems (Hawksworth 1991) , few studies aiming at the discovery of bioactive compounds from basidiomycetes were conducted in Brazil. Most of the investigations were directed to edible mushrooms (Ishikawa et al. 2001 , Paccola et al. 2001 , Oliveira et al. 2002 or common, easily recognized species (Smânia et al. 1995a (Smânia et al. ,b, 1997 (Smânia et al. , 1999 .
This work is part of a screening program aiming at the discovery of new bioactive metabolites from Brazilian basidiomycetes. We report herein the results of the collection, identification and screening of 84 species (103 isolates) of basidiomycetes in a bioassay panel employing five yeast and 12 bacteria of clinical importance.
MATERIALS AND METHODS
Fungi -One hundred and three basidiomycetes isolates from 84 species were collected at different locations in Brazil (Table I) . The extracts were prepared from the basidiomes and from culture in liquid media. The basidiomes were collected in the Parque Estadual do Rio Doce (MG), and in the Reserva do Museu de História Natural da Universidade Federal de Minas Gerais (UFMG). The culture isolates were obtained from Basidiomycetes Culture Collection (CCB) of the Instituto de Botânica (SP) and from the some basidiomes colleted at Parque Estadual do Rio Doce (MG), Estação Ecológica (MG) and Reserva do Museu de História Natural da UFMG. Axenic cultures were obtained from the inner fragments of the living tissues of the fruitbodies using Potato Dextrose Agar (PDA, Difco, US) medium supplemented with chloramphenicol (200 µg/l) (Sigma, US). They were deposited in the culture collection CCB of the Instituto de Botânica and UFMGCB (Coleção de Culturas de Basidiomicetos da Universidade Federal de Minas Gerais). All isolates were maintained in Malt Extract Agar medium (MEA, Difco) and preserved as agar plugs in distilled water at 4 o C (Castellani 1967) . The collected specimens were identified according to methods of classical herbarium taxonomy. The main taxonomic works of Dennis (1970) , Heinemann (1961 Heinemann ( , 1977 Heinemann ( , 1993 , Pegler (1983 Pegler ( , 1997 , Ryvarden (1986, 1987) , Ryvarden (1987 Ryvarden ( , 1991 were used to identify the species.
Growth conditions -Pre-inocula for the cultures were prepared by aseptically transferring three 5 mm discs from the culture on MEA slants into unbaffled 250 ml Erlenmeyer flasks containing 25 ml of MEC medium (malt extract 2%, peptone 0.1%, glucose 1.5%). The flasks were shaken at 150 rpm and 28°C for five days. The contents of the preinocula flasks were transferred to 250 ml Erlenmeyer flasks containing 100 ml of MEC. The inoculated flasks were shaken at 150 rpm at 28°C for nine days. The flasks were frozen (-20°C) until extraction.
Extraction -The cultures were thawed at ambient temperature and homogenised using a high-speed blender. The homogenate was extracted with ethyl acetate (5 x 30 ml) and the organic fraction dried over anhydrous sodium The yeasts were maintained on GYMP agar slant medium, containing 2% glucose, 0.5 yeast extract, 1% malt extract, 0.2% Na 2 PO 4 , and 2% agar (wt/vol) with a mineral oil layer and kept at 4°C and subcultured every six months. Bacteria were maintained on brain heart infusion broth (BHI, Difco, US) with a mineral oil layer, kept at -40°C.
Inocula of the target microorganisms were adjusted to Mac Farland nr 1 scale in optical density for yeasts (Yarrow 1998 ) and 10 3 -10 4 cells/ml for bacteria. The yeasts were grown in Agar Sabouraud (Difco) at 37°C for 24 h and inoculated using a swab onto a plate containing YM medium (malt extract 0.3%, yeast extract 0.3%, peptone 0.5%, glucose 1%, agar 2%). The bacteria were grown in Agar Nutrient (peptone 1%, NaCl 0.5%, beef extract 0.3%, agar 2%), transferred to culture tubes with 6 ml BHI (Difco) and incubated at 35ºC for 24 h. Before the assay, they were plated using a swab in BHI Agar (Difco).
The extract solutions at 1 mg/ml in aqueous 5% DMSO were applied (10 µl) on the Petri dishes (90 x 15 mm) with the target organisms and incubated for 24-48 h at 37°C. Inhibition zones around the application points were then measured. Fluconazole (12 mg/ml) and chloramphenicol (0.2 mg/ml) were used as positive controls for yeasts and bacteria, respectively. Solvent (aqueous DMSO 5%) was used as negative control.
RESULTS AND DISCUSSION
From the 103 extracts obtained, 15 (14%) presented significant activity against one or more of the target microorganisms (Table II) , generating inhibition halos larger than 12 mm diameter. Two extracts presented wide antimicrobial spectrum, and were active against both fungi and bacteria. Eight isolates were active against bacteria only while three inhibited the growth of fungi only.
The culture extract of Irpex lacteus was the most active, being able to inhibit the growth of C. albicans, C. glabrata, C. parapsilosis, B. cereus, E. coli, S. typhimurium, and S. aureus. Although this species is already known to produce a nematicidal compound (5-pentyl-2-furaldehyde) (Hayaschi et al. 1981) , this is the first work reporting the antibiotic activity of this species. Another species [I. pachyodon (P.) Quél.] was reported to produce an active principle that inhibits the growth of E. coli, S. aureus and B. subtilis (Bianco et al. 1969) .
Two Oudemansiella species, O. mucida and O. radicata, are known to produce several bioactive compounds denominated strobilurins and oudemansins. They are able to inhibit fungal growth at very low concentrations (10 -8 -10 -7 M) without any significant antibacterial activity (Anke et al. 1979 , Anke 1990 , Florianowicz 1999 . These compounds kill opportunist pathogens such as C. albicans and dermatophytes belonging to the genus Trichophyton, Epidermophyton, and Microsporum (Anke 1997) . In this work, the culture extract of O. canarii CCB179 presented a wide antifungal spectrum, inhibiting the growth of C. albicans, C. glabrata, C. krusei and C. tropicalis. Although this is the first report on the antifungal activity of this species it is reasonable to expect that the observed activity be due to the presence of one more compound already isolated from other Oudemansiella species.
Extracts from the basidiomes of Phellinus sp., Gloeoporus thelephoroides and Hexagonia hydnoides inhibited B. cereus growth while the extract from the culture of Nothopanus hygrophanus presented inhibitory activity against L. monocytogenes and S. aureus. This is the first report on the antibacterial activity of these species. Hwang et al. (2000) isolated the antifungal agent phellinsin A from Phellinus sp., capable of inhibiting the chitin synthase I and II of Saccharomyces cerevisiae with an IC 50 value of 76 µg/ml. Phellinsin A was able to inhibit the growth of fungi such as Colleotrichum lagenarium, Pyricularia oryzae, Rhizoctonia solani, Aspergillus fumigatus and Trichophyton mentagrophytes (Hwang et al. 2000) . Several studies have showed that Phellinus species can produce substances with cytotoxic (Atsumi et al. 1990 , 1993 , Withers & Umezawa 1991 , Han et al. 1999 , immunomodulatory (Song et al. 1995 , Kim et al. 1996 , antiviral (Walder et al. 1995) , antioxidant, antihepatotoxic (Ajith & Janardhnan 2002) activities.
The culture extract of Agrocybe perfecta was investigated for the first time and it displayed antifungal activity towards C. krusei. Species from this genus are known to produce bioactive compounds presenting antitumoral (Mavoungou et al. 1987) , antifungal (Pujol et al. 1990 ), hypocholesterolemic, hypolipidemic (Wasser & Weis 1999) activity as well as antibacterial activity against S. aureus and E. coli (Hervey 1947 ). Agrocybin, a compound able to halt the growth of Gram-positive, Gramnegative and acid-fast bacteria, was isolated from Agrocybe dura (Kavanagh et al. 1950) . Its activity against B. mycoides, B. subtilis, E. coli, Klebisiella pneumoniae, Mycobacterium pheli, M. smegmatis, Photobacterium fischeri, P. aeruginosa and S. aureus was demonstrated. Agrocybe cylindracea produces indole derivatives that act as radical scavengers and reduce lipid peroxidation of cells and organelles membranes (Kim et al. 1997) . Thus, rat liver microsomes are protected by these compounds with ED 50 values around 2 µg/ml. Berg et al. (2002) report the isolation of agrocybolacton from Agrocybe sp. This compound shows moderate antibacterial activity against (Anke et al. 1980) . M. androsaceus produces a compound with antiinflammatory activity that is already commercialized (Wasser & Weis 1999) . Scorodonin, a biologically active metabolite from M. scorodonius, inhibits Gram-negative and Gram-positive bacteria as well as yeasts at rather high concentration (Anke et al. 1980) . Two antimicrobial and cytotoxic metabolites denominated alliacols A and B were isolated from M. alliaceus. Although the alliacols show only weak antibacterial and antifungal activity, both antibiotics strongly inhibit DNA synthesis in cells of the ascitic form of Ehrlich carcinoma at concentration of 2-5 µg/ml (Anke et al. 1981) . Marasmic acid was shown to be an antibacterial, antifungal, cytotoxic, phytotoxic substance isolated from M. conigenus (Abraham 2001) .
The culture extract from Agaricus cf. nigrecentulus showed antibacterial activity against S. saprophyticus. Several lectins were isolated from A. bisporus, A. blazei, A. campestris, and A. edulis (Vijayan & Chandra 1999) . Nearly sixty lectins with ability to retard cancer cell growth, without any apparent effect on normal cells, were isolated from A. bisporus and are commercially available (Wang et al. 1998) . From the poisonous fungi A. xanthodermus several substances with antimicrobial, cytotoxic and antineoplastic activity were isolated (Dornberger et al. 1986 ). Culture extracts from Leucoagaricus cf. cinereus inhibited E. coli. Basidalin, isolated from L. naucinus showed weak antibacterial activity against Aeromonas salmonicida (MIC 100 µg/ml), Vibrio anguillarum (MIC 100 µg/ml), and inhibited the synthesis of protein, RNA and DNA in cultured L1210 cells, the IC 50 were 0.4-0.6 µg/ml (Iinuma et al. 1983) . To the best of our knowledge, the species Climacodon pulcherrimus and Tyromyces duracinus are cited here for the first time as producers of antimicrobial compounds.
The antimicrobial activity of Pycnoporus sanguineus has been known since 1946, when Bose (1946) isolated poliporin, a compound active against Gram-positive and Gram-negative bacteria and without toxicity to experimental animals. More recently, studies by Smânia et al. (1995a Smânia et al. ( , 1997 showed that this basidiomycete produces cinnabarine, an orange pigment active against B. cereus, E. faecalis, E. faecium, E. coli, K. pneumoniae, L. mesenteroides, L. plantarum, P. aeruginosa, Salmonella sp., S. typhi, S. aureus and several Streptococcus spp. Cinnabarine was more active against Gram-positive than against Gram-negative bacteria. According to Fidalgo (1965) some Brazilian indigenous people use the basidiomes of P. sanguineus to stop haemorrhages. Our results showed that from the six isolates tested, only CCB277 inhibited C. krusei, L. monocytogenes and S. aureus. We also observed discrepancies between the biological activities of two different O. canarii isolates. This is not uncommon, as infra-specific genetic differences have already been observed (Suay et al. 2000) . Indeed, distinct secondary metabolites can be produced by cospecific isolates in other fungi, as already reported in the literature (Möller et al. 1996 , Peláez et al. 1998 , Okino et al. 2001 . Thus, if secondary metabolic diversity is of interest, it is important to keep different samples/isolates of the same species of basidiomycetes in the collections.
Studies aiming at the isolation and identification of the active compounds from the most promising extracts disclosed in this research are currently under way. To the best of our knowledge, this survey is the first to investigate the potential of Brazilian basidiomycetes isolates on a larger scale, and can serve to stimulate the investigation of this rich source of bioactive secondary metabolites.
